PSG5 and cervical carcinoma: The purified PSG toxin also exhibited significant inhibition against the proliferation of HeLa cervical cancer cells and A549 lung cancer cells at an IC50 value of 16.5 μg/ml (23.2 μM) and 22.45 μg/ml (31.65 μM) (Fig. 2).